Literature DB >> 432784

Plasma catecholamine levels and pulmonary dysfunction in sepsis.

J K Bocking, W J Sibbald, R L Holliday, S Scott, T Viidik.   

Abstract

In a retrospective analysis of 18 patients with sepsis and adult respiratory distress syndrome, we found that high plasma epinephrine and noradrenalin levels were associated with severe defects in oxygenation that accompany this disease. The result of previous experimental work support the concept that high plasma catecholamine levels augment already existing defects in the ventilation to perfusion ratio and increases the measured intrapulmonary shunt fraction. The results of this study do not, however, delineate whether or not the relationship between high circulating plasma catecholamine levels and severe adult respiratory distress syndrome is causal or simply a measurement of two indexes which reflect the severity of the underlying disease process.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 432784

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  4 in total

1.  Lung injury edema in dogs. Influence of sympathetic ablation.

Authors:  I M Dauber; J V Weil
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

Review 2.  Molecular events in the cardiomyopathy of sepsis.

Authors:  Michael A Flierl; Daniel Rittirsch; Markus S Huber-Lang; J Vidya Sarma; Peter A Ward
Journal:  Mol Med       Date:  2008 May-Jun       Impact factor: 6.354

3.  Osteopontin Expression in Cardiomyocytes Is Increased in Pediatric Patients With Sepsis or Pneumonia.

Authors:  Camila Iansen Irion; Kiera Parrish; Krista John-Williams; Sakir H Gultekin; Lina A Shehadeh
Journal:  Front Physiol       Date:  2018-12-10       Impact factor: 4.566

4.  Toward the Existence of a Sympathetic Neuroplasticity Adaptive Mechanism Influencing the Immune Response. A Hypothetical View-Part II.

Authors:  Emanuel Bottasso
Journal:  Front Endocrinol (Lausanne)       Date:  2019-09-18       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.